Over the years, prostate adenocarcinoma (PCa) confirms its significant social impact worldwide [1]. The diagnosis, identification of clinically significant disease, and clinical management of patients with PCa is increasingly relying on the use of prostate MRI (pMRI) [2–4]. Imaging evaluation, however, requires high-quality images in order to ensure adequate diagnostic accuracy [2] and to avoid inappropriate biopsy procedures [4–9]. Image quality can be affected by patient movements, rectal spas…